Towards precision medicine: The application of omics technologies in asthma management

Chiara Scelfo*, Carla Galeone, Francesca Bertolini, Marco Caminati, Patrizia Ruggiero, Nicola Facciolongo, Francesco Menzella

*Corresponding author for this work

    Research output: Contribution to journalJournal articleResearchpeer-review

    194 Downloads (Pure)

    Abstract

    Asthma is a chronic obstructive respiratory disease characterised by bronchial inflammation. Its biological and clinical features have been widely explored and a number of pharmacological treatments are currently available. Currently several aspects of asthma pathophysiological background remain unclear, and this is represent a limitation for the traditional asthma phenotype approach. In this scenario, the identification of new molecular and clinical biomarkers may be helpful in order to better understand the disease, define specific diagnostic tools and highlight relevant novel targets for pharmacological treatments. Omics technologies offer innovative research tools for addressing the above mentioned goals. However, there is still a lot to do both in the fields of basic research and in the clinical application. Recently, genome-wide association studies, microRNAs and proteomics are contributing to enrich the available data for the identification of new asthma biomarkers. A precise approach to the patient with asthma, particularly with severe uncontrolled asthma, requires new and specific therapeutic targets, but also proper tools able to drive the clinician in tailoring the treatment. On the other hand, there is a need of predictors to treatment's response, particularly in the field of biological drugs, whose sustainability implies a correct and precise selection of the patients. Translating acquired omics knowledge in clinical practice may address the unmet needs described above, but large-scale studies are required in order to confirm their relevance and effectiveness in daily practice. Thus in our opinion the application of omics is still lagging in the real-life setting.
    Original languageEnglish
    Article number423
    JournalF1000Research
    Volume7
    Number of pages8
    ISSN2046-1402
    DOIs
    Publication statusPublished - 2018

    Bibliographical note

    This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

    Keywords

    • Inflammation
    • Omics sciences
    • Precision medicine
    • Severe asthma

    Cite this

    Scelfo, C., Galeone, C., Bertolini, F., Caminati, M., Ruggiero, P., Facciolongo, N., & Menzella, F. (2018). Towards precision medicine: The application of omics technologies in asthma management. F1000Research, 7, [423]. https://doi.org/10.12688/f1000research.14309.2